Industries > Pharma > Therapeutic Respiratory Devices Market Forecast 2020-2030

Therapeutic Respiratory Devices Market Forecast 2020-2030

Forecasts and Analysis by Product Type, by Technology, by Filters and Geography, with Profiles of Leading Companies

PAGES: 193
SUBMARKET: Medical Devices

WOOCS 2.2.1
SKU: PHA0696 Categories: , Tags: ,

According to the report published by Visiongain, the Therapeutic Respiratory Devices market is estimated to be valued at approximately USD xx billion in 2019 and is expected to generate around USD xx billion by 2030, at a CAGR of around xx% between 2020 and 2030. The increasing prevalence of breathing diseases, including chronic obstructive lung disease and sleep apnea, is expected to lead to market growth. WHO estimates that 65 million people are affected by moderate to severe COPD. In addition, the world’s third leading cause of death is predicted to be COPD, as estimated by the WHO. The growing need for emergency treatments for prolonged diseases and prolonged lung disease treatment in children and adults is expected to boost market growth.

Physicians and patients prefer respiratory therapeutic appliances for the treatment of respiratory conditions, since these appliances offer both acute and chronic medical interventions. In the United States, about 12.7 million adults over 18 years reported having COPD, according to the Center for Disease Control and Prevention (CDC). WHO estimates also indicate that possible fatal respiratory conditions, such as tuberculosis, COPD and lung cancer, will be responsible.

Another key growth driver in this market is the increase in the prevalence of sleep apnea. In 2012, approximately forty million Americans were affected by chronic sleep disorder, according to statistics published by the National Sleep Foundation. The prevalence of obstructive sleep apnea in the U.S., with a diagnosis ratio of about 1 million per 22, was also calculated at 12 million. Due to increasing prevalence of cardiovascular diseases, high blood pressure, obesity, etc., the prevalence of this disease is expected to continue to increase during the forecast period. The market growth is expected to be driven by these factors.

Factors Affecting Jet Nebulizer Performance and Drug Delivery
Aerosol therapy has many factors to keep in mind for respiratory therapists. Nebuliser layout is a key determinant of the particle size and production efficiency that, in line with the factors mentioned below, ensures the ultimate quality of medication. There are several forms of nebulizers on the market and various studies have shown that there is a difference in performance between suppliers and even the same producing nebulizers.

Gas Flow and Pressure
Jet nebulizers are designed to operate with varying levels of pressure and compressed gas streaming. Every jet nebulizer model is designed for the best possible operation at a certain flow of 2–8 L / min that should be indicated on the label. When a jet nebulizer is operated with a lower flow or pressure, the particle size increases. For example, when driven by a compressor producing 13 psi, a jet nebulizer designed to work 6–8 L / min at 50psi produced greater particles. Thus, a compressor or gas supply that correlates to the planned designs of jet nebulizers should be matted. The stream of gas is also reversed in process of nebulization. Using a higher gas flow rate in aerosol therapy will decrease the amount of treatment time needed to deliver the set amount of drug.

Fill and Dead Volumes
Another factor which affects the efficiency of jet nebulizers is changing the fill volume. Studies show that nebulizers have increased efficiency due to a fixed dead volume, thereby reducing the proportion of death within the nebulizer by an increase in fill volume. While efficiency increases with a greater filling volume, the nebulization time also increases.

Gas Density
The gas density used to run a jet nebulizer can have a similar offsetting effect on aerosol deposition through the impact of aerosol output and particulate size. The aerosol supply with helium-oxygen mixtures (heliox) for instance can improve the lung deposition by up to 50%. Using heliox at the same flow rate as the air or oxygen, particle size and aerosol output are reduced and treatment times are increased. The heliox flow should therefore be increased 1,5-2 times to restore the size and output of the particle to air or oxygen levels.

Breathing Pattern
Breathing pattern influences aerosol deposition in the lower respiratory tract. The patient should be instructed to do tidal breathing with periodic deep breaths during aerosol therapy.

Device Interface
Medical aerosols can be used with a mask or a mouthpiece. Ideally, you should use a mouthpiece. The nose uses more aerosol than the mouth to filter, therefore it is advisable to use a mouthpiece. Mouthpieces for children and little children can not be used. Moreover, it may be uncomfortable to use a mouthpiece for long aerosol treatment. The use of a mask raises the quantity of aerosol put on the head, eyes and nose. It is essential that the person is advised to inhale through the mouth during an aerosol treatment, whether a mouthpiece or a face mask are used. Proper mask fit and design can optimize the inhaled dose and reduce deposition to the eyes. The respiratory therapist must keep all of these factors in mind when practicing or equipping patients.

Factors Affecting pMDI Performance and Drug Delivery
Many pMDIs are meant to provide an actuation medication dosage of 100 μm. Like other aerosol generators, the pMDI medication supplies amount to about 10-20% of the nominal dose per actuation. The aerosol particle size produced by the pMDI fine particle fraction is less than 5μm in aerodynamic diameter. Several factors affect the performance of pMDI and the delivery of aerosols. Comprehension of the impacts of these factors will improve the effectiveness of pMDIs in patients with pulmonary diseases.

The application of an inhaled dose and clinical effect of pMDI with pMDI should at least be equivalent to the correct use of pMDI. A spacer offers extra density that reduces the aerosol velocity of a pMDI to rising particle size. The persistence of aerosol or dosage of release is based on the spacer’s size and shape and the electrostatic effect on plastic spacer inner walls. Spacers minimize oral deposition but provide only limited protection against poor control of hand respiration. When using a spacer, it is important that the inhalation of the patient is coordinated slightly before the inhaler is activated. Many ranges need to detach the inhaler from the actuator of the distributor and insert it into a specific gap on the distance. It is important to understand that the dosage distribution in certain spacer models can be compromised if the system does not properly match the pMDI or if a specific orifice or actuator in the spacer is used. Clinicians or physicians sometimes create makeshift storage chambers with plastic containers (for instance, water bottles) or of other equipment (for example, toilet rolls of paper). This can work as a spacer and protect against lower dose with pMDI action before inhalation, but does not protect from exhalation. Also, their performance is variable, so they should not be considered as suitable replacements for a commercially available spacer.

Dry-powder inhalers are mobile, flow-driven, inspiratory inhalers administering dry pulp formulations. Inhalers are inspiratory inhalers. DPIs are propellant-free and breathable. The inspiratory work of the patient, both the inhaled volume and its inspiratory flow rate, generates the energy to break down small medicinal particles and disperses particles as aerosol emanating from the device. DPIs shall coordinate inhalation release of the drug. They were designed to overcome problems with the use of metered-dose inhalers. They are often prescribed to make the patient overall more user-friendly and predictable.

Increasing Sleep Apnea Obstructive Incidence Is One Of The Growth Factors
It was estimated that positive airways will dominate the market in 2016, accounting for over xx percent of the revenue share, with the fastest growth expected over the forecast period. The growth of this segment can be attributed to increasing sleep apnea obstructive incidence. This is due to lifestyle-related conditions such as obesity, alcohol use, smoking, and craniofacial malnormalities. In the United States at least 25 million people are reported to have obstructive sleep apnea by the 2014 National Healthy Sleep Awareness Project. Increasing use of these devices by the geriatric patient base is also responsible for the growth of therapeutic respiratory devices market.

Among the factors that drive the market for HEPA filter technology is the occurrence and propagation of respiratory diseases
With around xx percent of the revenue share, HEPA filter software dominated the market in 2014. Particle Air (HEPA) high efficiency filters are used on various therapeutic respiratory devices for the removal and retention of particulate matter. According to CDC recommendations, HEPA air filtration systems are needed for therapeutic tools. As in the United States. State Department of Energy, 99.97% of particles larger than 0.3 microns disable HEPA filters. In the next seven years, technological progress in the segment is expected to have a positive market impact. This includes washable HEPA filters and HEPA 4 technology, which is ranked by the filter at the minimum efficiency reporting value (MERV). It is used to assess the air filter’s ability to remove particles from the air.

Regional Market Outlook
Due to the large geriatric population base and the increased prevalence of chronic respiratory diseases, North America dominated the market in 2016. In addition, North American markets play a major part due to reimbursement available on the accounts of US healthcare centres, improved healthcare awareness, improved infrastructure, increased outpatient operations and economic growth favored by increased insurance cover. The health plans of government including Medicaid and Medicare with the help of CMS also fuel the development of the demand for therapeutic respiratory equipment in this area. These health plans cover the respiratory therapy using respiratory devices such as Continuous Positive Airway Pressure devices for treatment of COPD and Obstructive Sleep Apnea (OSA).

Due to the factors such as increasing prevalence of asthma in adults as well as in children and technical developments asia pacific is expected to grow most rapidly during the forecast period. According to statistics published by the Global Asthma Initiative (GINA), by 2025 an additional 100 million people with asthma are expected to be increased. In contrast, the growing need for domestic health care facilities in this region also has a high impact. In fact, the significant growth levels in this area over the forecast period are responsible for increasing disposable income and lifestyle-related changes.

What is the future of the Therapeutic Respiratory Devices market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.

We guarantee in this 193 page report you will receive the following key information –
• View Therapeutic Respiratory Devices market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Therapeutic Respiratory Devices revenue forecast
– Therapeutic Respiratory Devices connections forecast

• Examine 122 tables, charts, and graphs
– Let our analysts present you with a thorough assessment of the current and future Therapeutic Respiratory Devices market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Therapeutic Respiratory Devices sector

• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Therapeutic Respiratory Devices industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Therapeutic Respiratory Devices submarkets with individual forecasts and analysis from 2020-2030.
– Product Type submarket forecast 2020-2030
– Technology submarket forecast 2020-2030
– Filters submarket forecast 2020-2030

• Learn about the market prospects for the leading Therapeutic Respiratory Devices market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Therapeutic Respiratory Devices revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.

Product Type Revenue Forecast 2020-2030
Nebulizers revenue forecast 2020-2030
Compressor-based nebulizers revenue forecast 2020-2030
Piston based hand held nebulizer revenue forecast 2020-2030
Ultrasonic Nebulizer revenue forecast 2020-2030
Humidifiers revenue forecast 2020-2030
Heated humidifiers revenue forecast 2020-2030
Passover humidifiers revenue forecast 2020-2030
Integrated humidifiers revenue forecast 2020-2030
Built-In humidifiers revenue forecast 2020-2030
Stand-alone humidifiers revenue forecast 2020-2030
Oxygen Concentrators revenue forecast 2020-2030
Fixed oxygen concentrators revenue forecast 2020-2030
Portable oxygen concentrators revenue forecast 2020-2030
Positive Airway Pressure Devices revenue forecast 2020-2030
Continuous positive airway pressure devices revenue forecast 2020-2030
Auto-titrating positive airway pressure devices revenue forecast 2020-2030
Bi-level positive airway pressure devices revenue forecast 2020-2030
Ventilators revenue forecast 2020-2030
Adult ventilators revenue forecast 2020-2030
Neonatal ventilators revenue forecast 2020-2030
Capnographs revenue forecast 2020-2030
Gas Analyzers revenue forecast 2020-2030

Technology Revenue Forecast 2020-2030
Electrostatic Filtration revenue forecast 2020-2030
HEPA filter technology revenue forecast 2020-2030
Hollow fiber filtration revenue forecast 2020-2030
Microsphere separation revenue forecast 2020-2030

Filters Revenue Forecast 2020-2030
Nebulizer filters revenue forecast 2020-2030
Inlet filter revenue forecast 2020-2030
Replacement filter revenue forecast 2020-2030
Cabinet filter revenue forecast 2020-2030
Humidifier filters revenue forecast 2020-2030
Wick filters revenue forecast 2020-2030
Permanent cleanable filters revenue forecast 2020-2030
Mineral absorption pads revenue forecast 2020-2030
Demineralization cartridges revenue forecast 2020-2030
Positive airway pressure devices filter revenue forecast 2020-2030
Ultra fine foam inlet filters revenue forecast 2020-2030
Polyester non-woven fiber filters revenue forecast 2020-2030
Acrylic & Polypropylene fiber filters revenue forecast 2020-2030
Oxygen concentrator filters revenue forecast 2020-2030
HEPA filter revenue forecast 2020-2030
Cabinet filter revenue forecast 2020-2030
Pre-Inlet filter revenue forecast 2020-2030
Inlet filter revenue forecast 2020-2030
Micro disk filter revenue forecast 2020-2030
Felt intake filter revenue forecast 2020-2030
Bacterial filter revenue forecast 2020-2030
Hollow-membrane filter revenue forecast 2020-2030
Ventilator filters revenue forecast 2020-2030
Mechanical filters revenue forecast 2020-2030
HEPA Filters revenue forecast 2020-2030
ULPA Filters revenue forecast 2020-2030
Activated carbon filters revenue forecast 2020-2030
Electrostatic filters revenue forecast 2020-2030
Tribocharged filters revenue forecast 2020-2030
Fibrillated filters revenue forecast 2020-2030

by End User Revenue Forecast 2020-2030
Hospitals revenue forecast 2020-2030
Home Care Settings revenue forecast 2020-2030
Ambulatory Care Centers revenue forecast 2020-2030

• Understand the prospects for the 4 regional and the leading 12 national Therapeutic Respiratory Devices markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Therapeutic Respiratory Devices companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts

• Explore the factors affecting Therapeutic Respiratory Devices product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry

• Identify who the leading companies are in the Therapeutic Respiratory Devices industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Therapeutic Respiratory Devices companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.

Leading Companies in the Global Therapeutic Respiratory Devices Market
Thermax is a vaporizer manufacturer which is also involved in power vaporizer solutions. For example, the charts industry announced in June 2015. Similarly, Invacare acquired Dynamic Medical Systems, a California-based firm, in November 2011. The acquisition allowed Invacare to expand its market for chronic diseases in the West and to mark a national footprint for rental capacities.

The segment of therapeutics was the biggest market share in 2019. The large proportion of this sector was due to the growing prevalence of chronic diseases and geriatric populations. Aircraft therapy equipment industry is also divided into PAPs, ventilators, nebulisators, humidifiers, inhalers, portable resuscitators, nitric oxide feeders and oxygen hoods, that can be used for the production of positive airway pressure (PAP). The PAP sector accounted for the largest proportion of the respiratory treatments market in 2019. The high share of this segment is due to the increasing incidence of obstructed sleep apnea worldwide and the availability of reimbursement cover in developed countries like the United States and other parts of Europe for PAP devices and related supplies.

In 2019, hospitals played the biggest share of the market, largely due to their financial capabilities, which enabled them to buy high-price instruments and ensured a high share of hospitals in the market for the availability of trained professionals to use them. Home care settings are expected to witness the highest growth during the forecast period, mainly due to the development of compact and lightweight respiratory care devices that are easier to carry and operate.

Top Companies
Koninklijke Philips NV
Medtronic PLC
ResMed Inc
CareFusion Corporation
GE Healthcare
Becton, Dickinson and Company
Hamilton Medical
Hill-Rom Services Inc.
Airsep Corporation
Philips Healthcare
Compumedics Ltd.

To access the data contained in this document please email

Buy our report today Therapeutic Respiratory Devices Market Forecast 2020-2030: Forecasts and Analysis by Product Type, by Technology, by Filters and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Therapeutic Respiratory Devices Market Forecast 2020-2030

Download sample pages

Complete the form below to download your free sample pages for Therapeutic Respiratory Devices Market Forecast 2020-2030

Latest Pharma news

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021


Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021


Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021


Visiongain Publishes Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031

Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D by biopharmaceutical & pharmaceutical companies; growing respiratory health care awareness; and new product launches worldwide are some of the major factors that boosting the growth of global inhalation & nasal spray generic drugs market.

31 March 2021